Top of this page
Skip navigation, go straight to the content

Newsroom

Newsroom

Press Release

UCB and Amgen Resubmit Biologics Licence Application (BLA) for EVENITYTM (Romosozumab) to the U.S. FDA12 Jul 2018

UCB and Amgen Resubmit Biologics Licence Application (BLA) for EVENITYTM …

Read more
Transparency notification 12 Jul 2018

Transparency notification 

Read more
Transparency notifications BlackRock, Inc.06 Jul 2018

Transparency notifications BlackRock, Inc.

Read more

UCB Stories

Artistic representation of a partnership 17 Jul 2018

UCB seals manufacturing deal with Samsung

Read more
11 Jul 2018

UCB Innovator Joins PhRMA as Scholar at Aspen Ideas Festival

Read more
4 Jul 2018

Celebrating 10 years of innovating together

Read more

Social Media